JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
CALL
Knight Transportation
KNX
$10.6B
| $6.74M | ﹤0.01% |
+154,100
| New | +$6.33M |
2017 Q4
0 quarters
|
|
2327
Interface
TILE
$1.99B
| $6.73M | ﹤0.01% |
267,728
+92,093
| +52% | +$2.16M |
2015 Q2
10 quarters
|
|
|
NEWR
2328
DELISTED
New Relic, Inc.
NEWR
| $6.73M | ﹤0.01% |
116,502
+2,637
| +2% | +$143K |
2016 Q4
4 quarters
|
|
2329
Elbit Systems
ESLT
$32.6B
| $6.72M | ﹤0.01% |
50,422
-5,859
| -10% | -$839K |
2013 Q2
18 quarters
|
|
2330
NMI Holdings
NMIH
$2.86B
| $6.71M | ﹤0.01% |
394,713
+260,463
| +194% | +$4.07M |
2013 Q4
16 quarters
|
|
2331
Asbury Automotive
ABG
$3.2B
| $6.71M | ﹤0.01% |
104,820
-88,381
| -46% | -$5.52M |
2015 Q4
8 quarters
|
|
2332
Ironwood Pharmaceuticals
IRWD
$621M
| $6.7M | ﹤0.01% |
533,361
+509,947
| +2,178% | +$6.66M |
2014 Q3
13 quarters
|
|
|
DCOM
2333
DELISTED
Dime Community Bancshares
DCOM
| $6.69M | ﹤0.01% |
319,363
+11,828
| +4% | +$253K |
2015 Q1
11 quarters
|
|
2334
Sabra Healthcare REIT
SBRA
$4.9B
| $6.68M | ﹤0.01% |
356,010
-537,233
| -60% | -$10.7M |
2015 Q3
9 quarters
|
|
2335
iShares Micro-Cap ETF
IWC
$1.39B
| $6.68M | ﹤0.01% |
69,776
+69,315
| +15,036% | +$6.57M |
2017 Q1
3 quarters
|
|
|
WBA
2336
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $6.67M | ﹤0.01% |
91,800
-54,400
| -37% | -$3.83M |
2014 Q3
13 quarters
|
|
|
GDP
2337
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $6.66M | ﹤0.01% |
610,332
-1,000
| -0.2% | -$10.3K |
2017 Q2
2 quarters
|
|
2338
Federal Signal
FSS
$6.85B
| $6.66M | ﹤0.01% |
331,320
+64,201
| +24% | +$1.35M |
2013 Q2
18 quarters
|
|
|
RSX
2339
DELISTED
VanEck Russia ETF
RSX
| $6.66M | ﹤0.01% |
313,802
-220,117
| -41% | -$4.82M |
2014 Q3
13 quarters
|
|
|
NUVA
2340
DELISTED
NuVasive, Inc.
NUVA
| $6.65M | ﹤0.01% |
113,738
+77,811
| +217% | +$4.41M |
2013 Q2
18 quarters
|
|
2341
CALL
Fluor
FLR
$6.6B
| $6.64M | ﹤0.01% |
+128,600
| New | +$5.99M |
2017 Q4
0 quarters
|
|
|
DHF
2342
BNY Mellon High Yield Strategies Fund
DHF
$161M
| $6.63M | ﹤0.01% |
1,986,613
+38,378
| +2% | +$131K |
2015 Q3
9 quarters
|
|
|
UPL
2343
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $6.63M | ﹤0.01% |
731,492
+31,452
| +4% | +$275K |
2017 Q2
2 quarters
|
|
|
FINL
2344
DELISTED
Finish Line
FINL
| $6.62M | ﹤0.01% |
455,752
+422,301
| +1,262% | +$4.55M |
2013 Q2
18 quarters
|
|
2345
Arch Capital
ACGL
$32.2B
| $6.62M | ﹤0.01% |
218,742
-1,188,831
| -84% | -$38M |
2013 Q2
18 quarters
|
|
2346
Power Integrations
POWI
$2.88B
| $6.61M | ﹤0.01% |
179,698
+87,292
| +94% | +$3.33M |
2013 Q2
18 quarters
|
|
|
AYX
2347
DELISTED
Alteryx Inc
AYX
| $6.6M | ﹤0.01% |
261,176
+66,876
| +34% | +$1.61M |
2017 Q1
3 quarters
|
|
2348
PUT
Take-Two Interactive
TTWO
$38.1B
| $6.59M | ﹤0.01% |
+60,000
| New | +$6.55M |
2017 Q4
0 quarters
|
|
2349
NACCO Industries
NC
$274M
| $6.58M | ﹤0.01% |
174,686
-626,480
| -78% | -$25.2M |
2013 Q2
18 quarters
|
|
|
EGOV
2350
DELISTED
NIC Inc
EGOV
| $6.56M | ﹤0.01% |
394,981
+49,076
| +14% | +$828K |
2015 Q3
9 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.